-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Mereo BioPharma Group plc quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
- Mereo BioPharma Group plc Amortization of Intangible Assets for the quarter ending 31 Mar 2025 was $106,000, a 1.9% decline year-over-year.
- Mereo BioPharma Group plc annual Amortization of Intangible Assets for 2024 was $438,000, a 11% increase from 2023.
- Mereo BioPharma Group plc annual Amortization of Intangible Assets for 2023 was $395,000.